Indoleamine 2,3 dioxygenase as a prognostic and follow-up marker in melanoma. A comparative study with LDH and S100B

1. de Lecea, M.V.
2. Palomares, T.
3. Al Kassam, D.
4. Cavia, M.
5. Geh, J.L.C.
6. de Llano, P.
7. Muñiz, P.
8. Armesto, D.
9. Martinez-Indart, L.
10. Alonso-Varona, A.